Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

Gemcitabine 34Cisplatin 21Capecitabine 18Oxaliplatin 15Leucovorin 10Fluorouracil 10Irinotecan 8Erlotinib Hydrochloride 7pembrolizumab 5Bevacizumab 5Radiotherapy 4Carboplatin 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Watchful Waiting 3Taxes 3Sorafenib 3Platinum 3Interleukin-12 Subunit p35 3Immunohistochemistry 3Docetaxel 31,2-diaminocyclohexaneplatinum II citrate 3trifluridine tipiracil drug combination 2tremelimumab 2regorafenib 2durvalumab 2dehydroftorafur 2Trastuzumab 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gallbladder Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡